Aspirin Reduces Colorectal Cancer Recurrence by Over 50%

Aspirin use in patients with PIK3CA-mutated colorectal cancer reduces recurrence risk by over 50%, found a study published in the Journal of Clinical Oncology. The findings could lead to immediate changes…